[Hereditary glucose-6-phosphate dehydrogenase deficiency in newborn infants]

Pediatriia
|January 1, 1992
PubMed

Insights

Early diagnosis of glucose 6-phosphate dehydrogenase deficiency in newborns is crucial. This study reveals a significant prevalence of this enzyme deficiency in Azerbaijan, linked to various hemoglobinopathies.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Glucose 6-phosphate dehydrogenase (G6PD) deficiency is a common inherited red blood cell disorder.
  • Early detection is vital to prevent hemolytic anemia, especially in newborns.
  • Understanding prevalence and associations is key for public health strategies.

Purpose of the Study:

  • To establish normal glucose 6-phosphate dehydrogenase enzyme activity levels in healthy newborns.
  • To determine the prevalence of G6PD deficiency in a neonate population in Azerbaijan.
  • To investigate the association between G6PD deficiency and hemoglobinopathies.

Main Methods:

  • Analysis of 428 umbilical cord blood samples from neonates.
  • Enzyme activity assays for glucose 6-phosphate dehydrogenase.
  • Pedigree analysis for 37 neonates to confirm hereditary character.
  • Screening for various hemoglobinopathies.

Main Results:

  • Established normal enzyme activity ranges considering national and sexual variations.
  • Identified a considerable prevalence of G6PD deficiency in Azerbaijan (phenotypic frequency 8.64%, gene frequency 0.0623).
  • Found associations between G6PD deficiency and alpha-thalassemia, beta-thalassemia, hemoglobin S, and methemoglobinemia.

Conclusions:

  • The study provides the first evidence of a significant prevalence of G6PD deficiency in Azerbaijan.
  • Early diagnosis and genetic counseling are recommended for neonates in this region.
  • G6PD deficiency is frequently associated with other inherited blood disorders, necessitating comprehensive screening.

Related Concept Videos

Energy-requiring Steps of Glycolysis01:20

Energy-requiring Steps of Glycolysis

Glucose is the source of nearly all energy used by organisms. The first step of converting glucose into usable energy is called glycolysis. Glycolysis occurs in the cytosol of the cell over two phases: an energy-requiring phase and an energy-releasing phase. Over the first three steps, glucose is converted into different forms and attached to two phosphate groups donated by two ATP molecules, resulting in an unstable sugar. In the next two stages, the unstable sugar splits into two sugar...
Glycolysis: Preparatory Phase01:21

Glycolysis: Preparatory Phase

In cellular metabolism (the complete breakdown of glucose to extract energy),  glycolysis is the first step. Glycolysis takes place in the cytoplasm of both prokaryotic and eukaryotic cells. Glucose enters heterotrophic cells in two ways. One method is through secondary active transport, where the transport takes place against the glucose concentration gradient. The other mechanism uses a group of integral proteins called GLUT proteins, also known as glucose transporter proteins. These...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Other Glycolytic Pathways01:24

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...